These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM. Cancer Res; 2003 May 01; 63(9):2079-87. PubMed ID: 12727823 [Abstract] [Full Text] [Related]
11. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Petitclerc E, Strömblad S, von Schalscha TL, Mitjans F, Piulats J, Montgomery AM, Cheresh DA, Brooks PC. Cancer Res; 1999 Jun 01; 59(11):2724-30. PubMed ID: 10363998 [Abstract] [Full Text] [Related]
12. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Cao DJ, Guo YL, Colman RW. Circ Res; 2004 May 14; 94(9):1227-34. PubMed ID: 15044324 [Abstract] [Full Text] [Related]
13. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. Mousa SA, Lorelli W, Campochiaro PA. J Cell Biochem; 1999 Jul 01; 74(1):135-43. PubMed ID: 10381270 [Abstract] [Full Text] [Related]
14. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA. Angiogenesis; 2004 Jul 01; 7(3):213-23. PubMed ID: 15609076 [Abstract] [Full Text] [Related]
16. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE. Invest Ophthalmol Vis Sci; 2006 Apr 01; 47(4):1600-5. PubMed ID: 16565398 [Abstract] [Full Text] [Related]
17. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Shahan TA, Ziaie Z, Pasco S, Fawzi A, Bellon G, Monboisse JC, Kefalides NA. Cancer Res; 1999 Sep 15; 59(18):4584-90. PubMed ID: 10493512 [Abstract] [Full Text] [Related]
18. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties. Al-Fakhri N, Chavakis T, Schmidt-Wöll T, Huang B, Cherian SM, Bobryshev YV, Lord RS, Katz N, Preissner KT. Biol Chem; 2003 Mar 15; 384(3):423-35. PubMed ID: 12715893 [Abstract] [Full Text] [Related]
19. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. Nat Med; 2002 Jan 15; 8(1):27-34. PubMed ID: 11786903 [Abstract] [Full Text] [Related]
20. Differential modulation of integrin expression in chondrocytes during expansion for tissue engineering. Goessler UR, Bugert P, Bieback K, Huber K, Fleischer LI, Hormann K, Riedel F. In Vivo; 2005 Jan 15; 19(3):501-7. PubMed ID: 15875768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]